Fortis Healthcare Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Fortis Healthcare Limited
Symbol
FORTIS
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Additional Disclosure Date
28-Apr-2026
Additional Disclosure Designation
CFO
Additional Disclosure Name Of Signatory
Vivek Kumar Goyal
Additional Disclosure Place
Gurugram
Additional Information Of Loans Or Guarantees Or Comfort Letters Or Securities Explanatory Text Block
The amount of Rs. 6376599999/- includes : (A) Intercorporate deposits given to entities related to erstwhile promoters- Rs. 44,503 lacs. (Including Interest accrued up to March 31, 2018) (B) Intercorporate deposits given for settlement of outstanding loans of certain parties including erstwhile promoters towards part funding of a property in Birdie & Birdie Realtors Private Limited, (FHL Group Company) the valuation of which is under investigation- Rs. 12,275 lacs. Consequent to NCLT Orders received during the current year ended March 31, 2026, Birdie & Birdie Realtors Private Limited has been merged with Fortis Hospitals Limited (FHL Group Company). Accordingly, aforesaid amount of Rs. 12,275 lacs has been eliminated in the books of account being Intercorporate deposits. (C) Inter corporate deposits to subsidiaries for repayment of outstanding loans of entities related to erstwhile promoter- Rs. 1,010 lacs. Out of it, consequent to NCLT Orders received during the current year ended March 31, 2026, Fortis Emergency Services Limited (FHL Group Company) has been merged with Fortis Hospitals Limited. Accordingly, an amount of Rs. 215 lacs has been eliminated in the books of account being Intercorporate deposits.
Advertisements As Per Regulation471
Yes
Affirmations
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Yes
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
6376599999
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance Status
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
28-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.fortishealthcare.com/investors/annual-return/479
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.fortishealthcare.com/investors/investor-presentations-&-transcripts/494
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.fortishealthcare.com/investors/newspaper-publications/521
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.fortishealthcare.com/investor/policies%20&%20code/dividend%20distribution%20policy
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20determination%20of%20materiality%20of%20events%20&%20information
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.fortishealthcare.com/investors/financials-of-subsidiaries/478
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.fortishealthcare.com/investors/credit-ratings/519
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.fortishealthcare.com/about-us
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.fortishealthcare.com/investor/policies%20&%20code/whistle%20blower%20policy
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.fortishealthcare.com/investors/outcome-of-board-meeting/516
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20material%20subsidiary
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.fortishealthcare.com/investor/policies%20&%20code/policy%20on%20related%20party%20transactions
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.fortishealthcare.com/investors/shareholding-pattern/498
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.fortishealthcare.com/investors
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.fortishealthcare.com/investors
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.fortishealthcare.com/investors
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.fortishealthcare.com/investors/disclosure-under-reg.-30-of-sebi-(lodr)/513
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.fortishealthcare.com/investor/miscellaneous/esop%20scheme-2026-approved%20by%20shareholders
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.fortishealthcare.com/investor/agm%202024/moa%20&%20aoa_fortis%20healthcare%20limited
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.fortishealthcare.com/investors/conference-call-invite/496
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.fortishealthcare.com/investors/annual-secretarial-compliance-report/482
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE061F01013
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Mr. Satyendra Chauhan
Name Of Signatory Affirmations
Mr. Satyendra Chauhan
Name Of Signatory For Annual Affirmations
Mr. Satyendra Chauhan
Name Of Signatory For Quartely Affirmations
Mr. Satyendra Chauhan
Name Of The Company
Fortis Healthcare Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Gurugram
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
f00057
Scrip Code
532843
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
FORTIS
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Any Guarantee Or Comfort Letter Of KM Ps Or Any Other Entity Controlled By Them
0
Type Of Any Guarantee Or Comfort Letter Of Promoter Group Or Any Other Entity Controlled By Them
0
Type Of Any Guarantee Or Comfort Letter Of Promoter Or Any Other Entity Controlled By Them
0
Type Of Company
Equity
Type Of Security Of KM Ps Or Any Other Entity Controlled By Them
0
Type Of Security Of Promoter Group Or Any Other Entity Controlled By Them
0
Type Of Security Of Promoter Or Any Other Entity Controlled By Them
0
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
Yes

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit10
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit11
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit12
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit9
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrLeo Puri******01764813Non-Executive - Independent DirectorChairperson03-Jan-1961NoActiveNot Applicable27-Dec-2024162211
2MrIndrajit Banerjee******01365405Non-Executive - Independent DirectorNot Applicable14-Jan-1956NoActiveNot Applicable27-Apr-201827-Apr-2023952253
3MrAshutosh Raghuvanshi******02775637Executive DirectorNot ApplicableCEO-MD11-Aug-1962NoActiveNot Applicable19-Mar-201919-Mar-20251010
4MsSuvalaxmi Chakraborty******00106054Non-Executive - Independent DirectorNot Applicable22-Jul-1966NoActiveNot Applicable27-Apr-201827-Apr-2023952243
5MrDilip Kadambi******02148022Non-Executive - Non Independent DirectorNot Applicable02-Aug-1974NoActiveNot Applicable04-Jun-20201000
6MrAshok Pandit******09279899Non-Executive - Non Independent DirectorNot Applicable24-Dec-1965NoActiveNot Applicable13-Sep-20231030
7MrPrem Kumar Nair******10348774Non-Executive - Non Independent DirectorNot Applicable25-Aug-1960NoActiveNot Applicable10-Nov-20231000
8MrKeith Hsiu Chin Lim******11276851Non-Executive - Non Independent DirectorNot Applicable21-May-1974NoActiveNot Applicable09-Sep-20251000
9MrMohd Shahazwan Bin Mohd Harris******08465456Non-Executive - Non Independent DirectorNot Applicable24-Dec-1971NoActiveNot Applicable19-Dec-20251000

Committee Disclosures

Entry CompComit122
Date of Appointment
27-Jul-2021
Entry CompComit123
Date of Appointment
13-Nov-2018
Entry CompComit124
Date of Appointment
27-Jun-2025
Entry CompComit14
Date of Appointment
13-Nov-2018
Entry CompComit15
Date of Appointment
30-Oct-2023
Entry CompComit16
Date of Appointment
13-Nov-2018
Entry CompComit41
Date of Appointment
27-Jun-2025
Entry CompComit42
Date of Appointment
13-Nov-2018
Entry CompComit43
Date of Appointment
10-Nov-2023
Entry CompComit68
Date of Appointment
13-Nov-2018
Entry CompComit69
Date of Appointment
27-Jul-2021
Entry CompComit70
Date of Appointment
27-Jun-2025
Entry CompComit95
Date of Appointment
27-Jun-2025
Entry CompComit96
Date of Appointment
15-Oct-2020
Entry CompComit97
Date of Appointment
29-Sep-2023
Entry CompComit98
Date of Appointment
15-Oct-2020
Entry CompComit99
Date of Appointment
15-Oct-2020
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.fortishealthcare.com/investors/composition-of-committees/485
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
No
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
01365405
Member Name
Indrajit Banerjee
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
09279899
Member Name
Ashok Pandit
Position
Non-Executive - Non Independent Director

Audit Committee

Additional Position
Member
Director DIN
00106054
Member Name
Suvalaxmi Chakraborty
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
02775637
Member Name
Ashutosh Raghuvanshi
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
01365405
Member Name
Indrajit Banerjee
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
09279899
Member Name
Ashok Pandit
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00106054
Member Name
Suvalaxmi Chakraborty
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01365405
Member Name
Indrajit Banerjee
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10348774
Member Name
Prem Kumar Nair
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
01764813
Member Name
Leo Puri
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
02775637
Member Name
Ashutosh Raghuvanshi
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
02148022
Member Name
Dilip Kadambi
Position
Non-Executive - Non Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
03551067
Member Name
Bishnu Prasad Panigrahi
Notes
Pursuant to the provisions of Regulation 21 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, Risk Management Committee of the Company is constituted with following members: 1. Mr. Dilip Kadambi, Non-Executive Director, Member 2. Dr. Ashutosh Raghuvanshi, MD & CEO, Member 3. Mr. Anil Vinayak, Group Chief Operating Officer, Member 4. Dr. Bishnu Panigrahi, Head - Group Medical Strategy and Operations, Member 5. Leo Puri, Non-Executive Independent Director, Chairperson
Position
Head Group Medical Strategy and Operations

Risk Management Committee

Additional Position
Member
Director DIN
02407380
Member Name
Anil Vinayak
Notes
Pursuant to the provisions of Regulation 21 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, Risk Management Committee of the Company is constituted with following members: 1. Mr. Dilip Kadambi, Non-Executive Director, Member 2. Dr. Ashutosh Raghuvanshi, MD & CEO, Member 3. Mr. Anil Vinayak, Group Chief Operating Officer, Member 4. Dr. Bishnu Panigrahi, Head - Group Medical Strategy and Operations, Member 5. Leo Puri, Non-Executive Independent Director, Chairperson
Position
Group Chief Operating Officer

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
01365405
Member Name
Indrajit Banerjee
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02775637
Member Name
Ashutosh Raghuvanshi
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
09279899
Member Name
Ashok Pandit
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
01-Oct-2025
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
9
Entry MeetingBOD2
Dates Of Meeting In The Previous Quarter
11-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
40
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
9
Entry MeetingBOD3
Dates Of Meeting In The Previous Quarter
26-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
14
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
9
Entry MeetingBOD4
Dates Of Meeting If Any In The Relevant Quarter
13-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
78
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
9
Entry MeetingBOD5
Dates Of Meeting If Any In The Relevant Quarter
19-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
33
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
9
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
04-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit10
Dates Of Meeting Of The Committee In The Previous Quarter
21-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit11
Dates Of Meeting Of The Committee In The Previous Quarter
15-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit12
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
158
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
6
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
13-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
93
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
18-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
32
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
4
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
13-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
93
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit9
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.fortishealthcare.com/investors
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.fortishealthcare.com/investor/grievance%20redressal/grievance%20redressal
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
There was no acquisition of shares or voting rights in Unlisted Companies during the Quarter and year ended March 31, 2026. However, the company through its wholly owned subsidiary i.e. International Hospital Limited (IHL) had executed definitive agreements on December 19, 2025, at 11:25 PM (IST) for the acquisition of 100% stake of TMI Healthcare Private Limited through a Share Purchase Agreement. The said transaction was disclosed to the stock exchanges on December 20, 2025. The acquisition was subsequently consummated and was reported to the stock exchange on January 9, 2026
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
No Change
Date of Initiation
09-Aug-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
On appeal by the Company (Fortis Hospitals Limited) for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 29.01.2021 with no adverse inference. Later on, Assessing Officer (AO) has passed assessment order dt. 09.08.2021 making disallowances: -Rs.3,26,81,835 u/s 14A -Rs.28,96,72,142 - unexplained cash credit u/s 68 computed as per section 115BBE @ 60%. Amount under litigation is Rs. 26,56,61,808 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes10
Current Status
No change
Date of Initiation
21-Mar-2024
Opposing Party
Income Tax Department
Status (Previous Disclosure)
Fortis Hospitals Limited, a material subsidiary of the Company has received an Income tax assessment order for Assessment Year 2022-23 (Financial Year 2021-22), wherein a demand of Rs.89.53 Crores (including interest of Rs.9.54 Crores) has been raised. The matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes11
Current Status
No change
Date of Initiation
18-Jul-2024
Opposing Party
Office of the Principal Commissioner” GST, Gurugram,
Status (Previous Disclosure)
GST Department of Haryana has issued Show Cause Notice alleging that the company i.e. Fortis Hospitals Limited is charging MRP from IPD patient for medicine, consumable and implant which include GST and not remitting the same to government exchequer. Thus, the subsidiary Company i.e . Fortis Hospitals Limited has filed the writ petition by challenging the show cause notice issued by the- Office of the Principal Commissioner GST, Gurugram. Amount under Litigation is Rs.61.19 Crore plus interest and penalty and the matter is currently pending before Punjab and Haryana High Court.
Entry I_OngoingTaxLitigationsOrDisputes12
Current Status
No change
Date of Initiation
03-Apr-2025
Opposing Party
Income Tax Department
Status (Previous Disclosure)
In case of International Hospital Limited, Income Tax Demand order amounting to Rs.76,19,13,970/- has been raised to IHL vide Order under Section 147/143(3)/144C read with Section 144B of the Income Tax Act, 1961 in respect of Assessment year 2019-20 (Financial year 2018-19). An Appeal before Commissioner of Income Tax (Appeals) has been filed on 30.04.2025 and the same is currently pending.
Entry I_OngoingTaxLitigationsOrDisputes13
Current Status
Delhi High Court ("HC") has issued Hearing Order dated 19.12.2025 wherein HC has directed to the Company to file reply to SCN before GST department of Delhi . Reply filed with GST Authority and order passed confirming the demand subject to final adjudication by Delhi HC.
Date of Initiation
29-Sep-2025
Opposing Party
The Office of Commissioner, CGST, Audit-I, CR Building, IP Estate, New Delhi
Status (Previous Disclosure)
GST Department of Delhi has issued Show Cause Notice alleging that the company i.e. Escorts Heart Institute and Research Centre Limited is charging MRP from IPD patient for medicine or drugs and consumable which include GST and not remitting the same to government exchequer. Thus, the subsidiary Company i.e . Escorts Heart Institute and Research Centre Limited has filed the writ petition by challenging the show cause notice issued by the- Office of the Commissioner CGST, Audit-I, Delhi. Amount under Litigation is Rs.6.66 Crore plus interest and penalty and the matter is currently pending before Delhi High Court.
Entry I_OngoingTaxLitigationsOrDisputes14
Current Status
Appeal filed on 10th March 26
Date of Initiation
29-Dec-2025
Opposing Party
State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101
Status (Previous Disclosure)
In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2020-21, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.1.68 Crore along with Interest of Rs.1.42 Crore & penalty of Rs.1.68 Crore has been raised.
Entry I_OngoingTaxLitigationsOrDisputes15
Current Status
Appeal filed on 10th March 26
Date of Initiation
29-Dec-2025
Opposing Party
State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101
Status (Previous Disclosure)
In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2021-22, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.3.19 Crore along with Interest of Rs.2.17 Crore & penalty of Rs.3.19 Crore has been raised.
Entry I_OngoingTaxLitigationsOrDisputes16
Current Status
Appeal filed on 09th March 26
Date of Initiation
29-Dec-2025
Opposing Party
State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101
Status (Previous Disclosure)
In case of Fortis Health Management Limited, GST Department of Tamil Nadu has issued GST Order for FY 2022-23, wherein GST department has denied the exemption on supply of healthcare services. The Company is in process of filing appeal before GST Fist Appellat Authority. Amount under litigation is Rs.3.26 Crore along with Interest of Rs.1.59 Crore & penalty of Rs.3.26 Crore has been raised.
Entry I_OngoingTaxLitigationsOrDisputes17
Current Status
Appeal to be filed
Date of Initiation
27-Mar-2026
Opposing Party
Income Tax Department
Status (Previous Disclosure)
Income Tax Authority has issued assessment order dated 27.03.2026 for AY 2024-25 wherein demand of INR 117.04 Crores has been raised. The Company is evaluating all options including filing an appeal and rectification application against the said order.
Entry I_OngoingTaxLitigationsOrDisputes18
Current Status
Appeal to be filed
Date of Initiation
02-Jan-2026
Opposing Party
State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu-603101
Status (Previous Disclosure)
GST Authority had issued show cause notice for an amount of INR 570.00 lakhs (including penalty of INR 285.00 lakhs) for the FY 2023-24. On submission of response by the Company, GST Authority has passed order and confirmed demand of INR 597.93 lakhs (including interest & penalty of INR 79.29 lakhs & INR 259.32 lakhs respectively). The show cause notice in relation to balance amount has been dropped.
Entry I_OngoingTaxLitigationsOrDisputes19
Current Status
Appeal to be filed
Date of Initiation
27-Mar-2026
Opposing Party
Income Tax Department
Status (Previous Disclosure)
Income Tax Authority has issued assessment order dated 27.03.2026 for A.Y. 2021-22 wherein demand of INR 149.12 Crores has been raised. The Company is evaluating all options including filing an appeal and rectification application against the said order.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
No change
Date of Initiation
29-Sep-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
On appeal by the Company (Fortis Hospitals Limited) for Assessment Year 2019-20, Assessment was completed vide order dated 29.09.2021 making disallowances on account of: -14A r.w Rule 8D at Rs.5,37,26,805/- -Disallowance of bad debts at Rs.25,49,02,000/- -Advances from customers/patients at Rs.42,65,12,000/- -Disallowance of ICDs based on SEBI ordes at Rs.402,43,62,000/- Assessing income at Rs.108,58,49,650/- as against loss at Rs.367,36,53,160/- Amount under litigation is Rs. 44,04,72,119 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes20
Current Status
Disposed off in favour of assessee by Order of ITAT, dated 22/07/2025.
Date of Initiation
30-Nov-2018
Opposing Party
DCIT
Status (Previous Disclosure)
Disposed off in favour of assessee by Order of CIT (A), dated 27.05.2024. However DCIT, Income Tax – Gurugram filed an appeal before ITAT. Now the matter is pending with ITAT.
Entry I_OngoingTaxLitigationsOrDisputes21
Current Status
Pending before CIT(A) / NFAC
Date of Initiation
19-Jan-2018
Opposing Party
DCIT
Status (Previous Disclosure)
Pending before CIT(A) / NFAC
Entry I_OngoingTaxLitigationsOrDisputes22
Current Status
Pending before CIT(A) / NFAC
Date of Initiation
18-Jan-2019
Opposing Party
DCIT
Status (Previous Disclosure)
Pending before CIT(A) / NFAC
Entry I_OngoingTaxLitigationsOrDisputes23
Current Status
Pending before CIT(A) / NFAC
Date of Initiation
30-Jun-2020
Opposing Party
DCIT
Status (Previous Disclosure)
Pending before CIT(A) / NFAC
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
No change
Date of Initiation
11-Feb-2019
Opposing Party
Income Tax Department
Status (Previous Disclosure)
On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2015-16, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order proposing adjustment. Later on, Assessing Officer (AO) has passed assessment order confirming the adjustment proposed in TP Order, being interest amount paid on Compulsorily Convertible Debentures (CCDs) issued by the company. Amount under litigation is Rs. 71,18,64,960 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
No change
Date of Initiation
03-Jun-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order proposing adjustment. Later on, Assessing Officer (AO) has passed assessment order confirming the adjustment proposed in TP Order, being interest amount paid on Compulsorily Convertible Debentures (CCDs) issued by the company. Amount under litigation is Rs. 56,11,28,717 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes5
Current Status
No change
Date of Initiation
24-Nov-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
On appeal by the Company (Fortis Hospotel Limited) for Assessment Year 2018-19, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 30.07.2021 proposing adjustment amounting to INR 74.63 Cr which is interest expense claimed on Compulsorily Convertible Debentures (CCDs) issued by the company to FGHIPL and consultancy expenses on the same. Later on, Assessing Officer (AO) has passed assessment order dt. 24.11.2021 confirming the adjustment proposed in TP Order. Amount under litigation is Rs. 33,26,19,748 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes6
Current Status
No change
Date of Initiation
28-Mar-2005
Opposing Party
Income Tax Department
Status (Previous Disclosure)
In case of Escorts Heart Institute and Research Centre Limited, On appeal by the Department for Assessment Year 2001-02, Assessment was done u/s 143(1)(a) on 29.08.2002. The Assessing Officer reopened the assessment and passed the assessment order dated 28.03.2005 making an addition of Rs.149.09 crores. The Assessing Officer held that registration of a society as a company under Part IX of the Companies Act tantamount to a transfer of assets and hence alleged addition on account of capital gain has been made. Company’s appeal allowed by Income tax appellate tribunal, revenue has filed appeal before Delhi High Court. Amount under litigation is Rs. 1,05,32,00,000 and the matter is currently pending before Delhi High Court.
Entry I_OngoingTaxLitigationsOrDisputes7
Current Status
No change
Date of Initiation
15-Feb-2017
Opposing Party
Income Tax Department
Status (Previous Disclosure)
In case of International Hospital Limited for Assessment Year 2013-14, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order on 31.10.2016 proposing adjustment amounting to INR 569 million which is interest expense claimed on Compulsorily Convertible Debentures (CCDs) issued by the company to FGHIPL. Later on, Assessing Officer (AO) has passed assessment order dt. 15.02.2017 confirming the adjustment proposed in TP Order and also making disallowance u/s 14A read with rule 8D amounting to INR 60 million and u/s 36(i)(va) amounting to INR 0.26 million. An appeal filed before the Commissioner of Income-tax (Appeals), New Delhi on 30.03.2017 has been decided. Further appeal filed before ITAT on 18.04.2019. Departmental also in appeal. Demand raised at Rs.15,01,91,860/- vide order passed u/s 143(3), the same was revised at Rs.34,18,72,340/- vide order dated 17.05.2018 passed u/s 154. Amount under litigation is Rs. 34,18,72,340/- and the matter is currently pending before Income Tax Appellate Tribunal
Entry I_OngoingTaxLitigationsOrDisputes8
Current Status
No change
Date of Initiation
10-May-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
In case of International Hospital Limited for Assessment Year 2017-18, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order dated 11.01.2021 proposing adjustment of Rs.92,83,08,762/-. Later on, Assessing Officer (AO) has passed assessment order u/s 143(3) dated 10.05.2021 confirming the adjustment proposed in TP Order and making further disallowance u/s 36(1)(iii) at Rs.71,00,77,700/- and u/s 36(1)(va) at Rs.9,05,271/- thereby raising a demand of Rs.39.89Cr. Amount under litigation is Rs. 39,89,16,838/- and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry I_OngoingTaxLitigationsOrDisputes9
Current Status
No change
Date of Initiation
25-Nov-2021
Opposing Party
Income Tax Department
Status (Previous Disclosure)
In case of International Hospital Limited for Assessment Year 2018-19, Case was referred to Transfer Pricing Officer (TPO) for Transfer Pricing (TP) Assessment. TPO has passed order dated 30.07.2021 proposing adjustment of Rs.228,08,64,295/-. Later on, Assessing Officer (AO) has passed assessment order u/s 143(3) dated 25.11.2021 confirming the adjustment proposed in TP Order and making disallowance u/s 36(1)(iii) at Rs.75,05,77,475/- and u/s 36(1)(va) at Rs.12,00,000/- thereby raising a demand of Rs.187.35Cr. Amount under litigation is Rs. 1,87,35,22,640 and the matter is currently pending before Commissioner of Income Tax (Appeals).
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Entry I_ImpositionOfFineOrPenalty1
Authority
Income Tax
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
25-Mar-2026
Financial / Operational Impact
599217
Nature And Details Of The Action Taken Or Order Passed
Penalty u/s 270A of Rs.5,99,217 on account of disallowance of expense in assessment order for assessment year 2017-18
Violation Details
Penalty is pursuant to disallowance of expense as made by A.O. in assessment order for assessment year 2017-18.
Entry MainD
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
Yes